Regulatory Compliance, Industry Advisory
10 Jan 2025
regulatory compliance, advisory committee, fda, pharmaceutical, antimicrobial drugs
💊FDA Renews Antimicrobial Drugs Advisory Committee Through 2026
The Food and Drug Administration (FDA or the Agency) is announcing the renewal of the Antimicrobial Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Antimicrobial Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 7, 2026, expiration date.
Learn More